|
⚲
|
| Keyboard |
| Adawi Kamal
✚
|
|
|---|---|
| CIK # | 0001788393 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788393] | |
| 4 | [0001788393] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Adawi Kamal | |
| Fate Therapeutics Inc | |
| Exagen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fate Therapeutics Inc FATE
Common Stock
|
2026-01-15 | Grant | 25,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2026-01-15 | Grant | 75,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2025-10-20 | Grant | 75,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2025-10-20 | Grant | 375,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2024-03-04 | Sell | 3,487 | $1.91 | 6,660 |
|
Exagen Inc XGN
Common Stock
|
2024-03-04 | Sell | 9,297 | $1.91 | 17,757 |
|
Exagen Inc XGN
Common Stock
|
2024-02-20 | Grant | 75,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2024-02-06 | Sell | 6,738 | $1.95 | 13,139 |
|
Exagen Inc XGN
Common Stock
|
2023-03-02 | Sell | 3,667 | $2.30 | 8,434 |
|
Exagen Inc XGN
Common Stock
|
2023-02-27 | Grant | 100,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2023-02-08 | Sell | 5,821 | $2.69 | 15,658 |
|
Exagen Inc XGN
Common Stock
|
2022-03-01 | Tax withheld | 3,241 | $7.12 | 23,076 |
|
Exagen Inc XGN
Common Stock
|
2022-02-04 | Grant | 63,500 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2021-02-23 | Grant | 12,500 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2021-02-23 | Grant | 37,500 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2020-01-09 | Grant | 52,500 | $0.00 | |
|
Exagen Inc XGN
Stock Option (right to buy) · derivative
|
2019-09-18 | Grant | 21,635 | $0.00 |